Sanofi-aventis

Sanofi

Zoltán Kapui

Lajos T Nagy

Tibor Szabo

Zoltán Szlávik

Katalin Urban-Szabo

Sándor Bátori

László Balázs

Katalin Urbán-Szabó

Endre Mikus

Imre Bata

Kinga Boer

Edit Susan

Mária Balogh

Kinga Boér

Péter Arányi

Katalin Gerber

Eva Boronkay

Geza Tímári

Tibor Szabó

Zsuzsanna Szamosvölgyi

Géza Timári

Edit Susán

Éva Boronkay

T Nagy Lajos

Judit Vargáné Szeredi

Peter Arányi

Olivier Finance

Gábor Szeleczky

Márton Varga

Lászlo Balazs

Michel Finet

Katalin Urbán Szabó

Géza Timari

Péter Aranyi

Lászlö Balazs

Sándor Batori

Ágnes Pappné Behr

Veronika Bartáné Bodor

Heterocyclic amides useful as inhibitors of dipeptylpeptidase-IV (DPP-IV) enzyme, process for the preparation thereof and intermediates therefore.

Compounds

The present invention relates to adenosine Areceptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containings them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and (III) and to the preparation thereof. 

Imidazoquinoline derivatives and their use as adenosine A3 ligands

Compounds of general formula (I), wherein Rand Rstand for hydrogen atom or form together an 1,3-butadienyl group, optionally substituted by a methylenedioxy group or one or more straight or branched Calkyl group, straight or branched Calkoxy group, hydroxy group or halogen atom; are strong adenosine Areceptor ligands preferably antagonists.

Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands

Growing community of inventors

Budapest, Hungary

Zoltán Kapui